In October 2021, more than 300 goods, including 77 medical care products, were excluded from tariffs under the Section 301 tariff exclusion, with the aim to facilitate urgent care throughout the COVID-19 pandemic. The complete list of relevant goods is available here, affecting all products meeting the specified HTSUS numbers and product descriptions, regardless of whether the importer filed an exclusion request.

The exclusion review is part of an ongoing general tariff review on imports from China, which may result in the removal of some existing tariffs or the addition of new ones. The review is planned to be completed by the end of 2023, and any reimposed tariffs from the abovementioned exclusion will be added to the existing ones.

We will monitor any changes and provide prompt updates on the tariffs reviewed. At Woodland, we have decades of experience in customs management and our specialised teams offer customs brokerage, tariff classification and consultancy on duties, taxes, and risks, providing you with timely, cost-effective and personalised solutions to keep your goods moving.

We Deliver:

• Tariff suspension applications
• Outsourced customs department and support training
• Export compliance management
• Denied party lists
• Export controls
• Licensing
• Best practice and assured compliance
• Customs consultative services and health checks
• Regime management, such as CFSP, Warehousing and IP/OPR
• Purchase order management
• Retrospective reclaims
• Classification reviews
• Binding ruling
• Customs compliance reviews
• CTPAT gap analysis/CTPAT applications

Should you have any questions about our customs services or your global supply chain, please contact us here.